Use of nordihydroguaiaretic acid derivatives in the treatment of drug resistant cancer, viral and microbial infection

Details for Australian Patent Application No. 2005294432 (hide)

Owner Johns Hopkins University Mold, D. Lee, Y. Chang, C.

Inventors Chang, Chih-Chuan; Mold, David E.; Huang, Ru Chih C.; Hsu, Ming-Hua; Lee, Yuan C.; Hwu, Jih-Ru

Agent Davies Collison Cave

Pub. Number AU-A-2005294432

PCT Pub. Number WO2006/041902

Priority 60/616,114 06.10.04 US

Filing date 6 October 2005

Wipo publication date 20 April 2006

International Classifications

A61K 31/192 (2006.01)

Event Publications

26 April 2007 PCT application entered the National Phase

  PCT publication WO2006/041902 Priority application(s): WO2006/041902

8 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005294433-A method of cultivating animals to develop a desired color and to increase their rate of growth

2005294430-Substituted Naryl1H-pyrazolo[3,4-b]quinolin-4-amines and analogs as activators of caspases and inducers of apoptosis